Oral administration of fluoroquinolones in the treatment of typhoid fever and paratyphoid fever in Japan

Internal Medicine

Volumn 39, Issue 12, 2000, Pages 1044-1048

  Ohnishi, Kenji ^a   Kimura, Kyoko ^a   Masuda, Gohta ^b   Tsunoda, Takafumi ^c   Obana, Mitsuo ^d   Yoshida, Hideki ^e   Goto, Tetsushi ^e   Sakaue, Yoshihiro ^e   Kim, Young Ki ^f   Sakamoto, Mitsuo ^g   Sagara, Hiroko ^g  

^a TOKYO METROPOLITAN BOKUTOH HOSPITAL   (Japan)

^b TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^c Department of Dentistry Oral surgery   (Japan)

^d KAWASAKI MUNICIPAL HOSPITAL   (Japan)

^e OSAKA CITY GENERAL HOSPITAL   (Japan)

^f KYOTO CITY HOSPITAL   (Japan)

^g YOKOHAMA MUNICIPAL CITIZEN'S HOSPITAL   (Japan)

Author keywords

Adverse reaction; Antimicrobial agent; Therapeutic evaluation

Indexed keywords

AMYLASE; CIPROFLOXACIN; LEVOFLOXACIN; NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; TOSUFLOXACIN;

ADOLESCENT; ADULT; AGED; AMYLASE BLOOD LEVEL; ANTIBIOTIC THERAPY; APHTHOUS STOMATITIS; ARTICLE; CHILD; FEMALE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; RETROSPECTIVE STUDY; SALMONELLOSIS; TYPHOID FEVER; URTICARIA;

EID: 0034524343     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.39.1044     Document Type: Article

References (11)

1. Schwalbe RS, Hoge CW, Morris JG Jr, O'Hanlon PN, Crawford RA, Gilligan PH. In vivo selection for transmissible drug resistance in Salmonella typhi during antimicrobial therapy. Antimicrob Agents Chemother 34: 161-168, 1990.
2. Rowe B, Ward LR, Threlfall EJ. Spread of multiresistant Salmonella typhi. Lancet 336: 1065, 1990.
3. Wallace M, Yousif AA. Spread of multiresistant Salmonella typhi. Lancet 336: 1065-1066, 1990.
4. Asperilla MO, Smego RA Jr, Scott LK. Quinolone antibiotics in the treatment of Salmonella infections. Rev Infect Dis 12: 873-889, 1990.
5. Zavala Trujillo I, Quiroz C, Gutierrez MA, Arias J, Renteria M. Fluoroquinolones in the treatment of typhoid fever and the carrier state. Eur J Clin Microbiol Infect Dis 10: 334-341, 1991.
6. Graninger W, Zedtwitz-Liebenstein K, Laferl H, Burgmann H. Quinolones in gastrointestinal infections. Chemotherapy 42 (suppl 1): 43-53, 1996.
7. Kurimura O, Sasaki H, Aratani Y, et al. Further clinical studies of AM-715 on the patients with typhoid fever and typhoid carriers. Chemotherapy (Tokyo) 30: 1286-1296, 1982 (in Japanese, Abstract in English).
8. Ohnishi K, Murata M, Ajima I, Saku K, Nakamura A. Treatment of typhoid fever with tosufloxacin. J J A Inf D 66: 1295-1296, 1992 (in Japanese).
9. Kurimura O, Ichimura H, Tsubakio T, et al. Studies on the clinical and bacteriological effects of ofloxacin on the typhoid patients and carriers. J J A Inf D 63: 623-632, 1989 (in Japanese, Abstract in English).
10. Kurimura O, Ooishi A, Tamura R, Doi H. Efficacy of levofloxacin on typhoid fever. J J A Inf D 66: 794-795, 1992 (in Japanese, Abstract in English).
11. Murdoch DA, Banatvala N, Bone A, Shoismatulloev BI, Ward LR, Threlfall EJ. Epidemic ciprofloxacin-resistant Salmonella typhi in Tajikistan. Lancet 351: 339, 1998 (published erratum appears in Lancet 351: 1592, 1998).